Compounds > resveratrol
Page last updated: 2024-08-16

resveratrol and 3,4,4'-trihydroxy-trans-stilbene

resveratrol has been researched along with 3,4,4'-trihydroxy-trans-stilbene in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cushman, M; Geahlen, RL; Thakkar, K1
Croy, VL; Cuendet, M; Endringer, DC; Kang, SS; Lipton, MA; Pezzuto, JM1
Cai, YJ; Fan, GJ; Fang, JG; Li, XZ; Qian, YP; Wei, QY; Yang, J; Zheng, LF; Zhou, B1
Calamini, B; Chen, Y; Jensen, KC; Kang, S; Lipton, MA; Mesecar, AD; St John, SE1
Nakanishi, I; Sekine-Suzuki, E; Sonoda, M; Tanimori, S; Uzura, S1
Dai, Y; Kogure, Y; Mabuchi, M; Nakao, S; Noguchi, K; Shimizu, T; Tanaka, A; Wang, S1

Other Studies

6 other study(ies) available for resveratrol and 3,4,4'-trihydroxy-trans-stilbene

ArticleYear
Synthesis and protein-tyrosine kinase inhibitory activity of polyhydroxylated stilbene analogues of piceatannol.
    Journal of medicinal chemistry, 1993, Oct-01, Volume: 36, Issue:20

    Topics: Hydroxylation; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Lymphocytes; Molecular Structure; Phenols; Protein-Tyrosine Kinases; Stilbenes; Structure-Activity Relationship

1993
Synthesis and biological evaluation of a library of resveratrol analogues as inhibitors of COX-1, COX-2 and NF-kappaB.
    Bioorganic & medicinal chemistry, 2009, Feb-01, Volume: 17, Issue:3

    Topics: Antioxidants; Cell Line; Combinatorial Chemistry Techniques; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; Inhibitory Concentration 50; NF-kappa B; Resveratrol; Small Molecule Libraries; Stilbenes; Structure-Activity Relationship

2009
Antioxidant-based lead discovery for cancer chemoprevention: the case of resveratrol.
    Journal of medicinal chemistry, 2009, Apr-09, Volume: 52, Issue:7

    Topics: Animals; Anticarcinogenic Agents; Antioxidants; Apoptosis; Cations, Divalent; Cell Survival; Copper; DNA Damage; HL-60 Cells; Humans; Hydrogen Peroxide; In Vitro Techniques; Leukocytes, Mononuclear; Mice; Mice, Inbred BALB C; Oxidants; Reactive Oxygen Species; Resveratrol; Stilbenes; T-Lymphocytes

2009
Design, synthesis, biological and structural evaluation of functionalized resveratrol analogues as inhibitors of quinone reductase 2.
    Bioorganic & medicinal chemistry, 2013, Oct-01, Volume: 21, Issue:19

    Topics: Anilides; Catalytic Domain; Crystallography, X-Ray; Drug Design; Enzyme Activation; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Molecular Structure; Quinone Reductases; Resveratrol; Small Molecule Libraries; Stilbenes

2013
A facile and rapid access to resveratrol derivatives and their radioprotective activity.
    Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16

    Topics: Animals; Apoptosis; Boronic Acids; Catalysis; Gamma Rays; Oxidation-Reduction; Palladium; Radiation-Protective Agents; Rats; Resveratrol; Stilbenes; Structure-Activity Relationship; Styrenes; Thymocytes

2016
Synthesis of resveratrol derivatives as new analgesic drugs through desensitization of the TRPA1 receptor.
    Bioorganic & medicinal chemistry letters, 2017, 07-15, Volume: 27, Issue:14

    Topics: Analgesics; Animals; Calcium Channels; Ganglia, Spinal; HEK293 Cells; Humans; Inhibitory Concentration 50; Nerve Tissue Proteins; Pain; Patch-Clamp Techniques; Rats; Resveratrol; Stilbenes; Transient Receptor Potential Channels; TRPA1 Cation Channel

2017